- Price
- $78.31
- Day
- +2.99%
- Mkt Cap
- $52.38B
- 52W Range
- $60.54 – $90.97
- Volume
- 6.81M
- Beta
- 0.56
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
Corteva, Inc. will split into two companies—New Corteva (Crop Protection) and Vylor (Seed)—with the breakup expected in Q4 2026. Both CTA.PR.A and CTA.PR.B preferred stocks will remain with New Corteva, which retains strong equity and income coverage post-split. Preferreds offer investment-grade BBB ratings, cumulative dividends, low call risk, and diversification beyond financial issuers.
Read full article
Corteva, Inc. (CTVA) Q2 2026 Earnings Call Transcript
Read full article
Does Corteva, Inc. (CTVA) have what it takes to be a top stock pick for momentum investors? Let's find out.
Read full article
CTVA's Q2 EPS beats estimates as Seed pricing and productivity lift margins; sales fall 1% and the company raises its 2026 outlook.
Read full article
Corteva NYSE: CTVA raised its full-year outlook after reporting higher first-half sales, earnings and margins, citing demand for its seed technologies, growth in new crop-protection products, licensing income and cost discipline. The agricultural company also said it remains on schedule to separate its businesses on Oct. 1, with its advanced seed and genetics company expected to operate as Vylor.
Read full article
Release Date: July 31, 2026For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Strong first-hal
Read full article
Corteva, Inc. stands as a global leader in pure agri-tech, emphasizing R&D for advanced seed genetics and sustainable crop solutions. My prior Hold ratings on CTVA underestimated the market's preference for quality, execution, and improved business visibility over strict valuation metrics. CTVA has significantly outperformed the broader market by four times and its ETF peers by more than two times since my earlier reviews.
Read full article
While the top- and bottom-line numbers for Corteva, Inc. (CTVA) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Read full article
Corteva, Inc. (CTVA) came out with quarterly earnings of $2.3 per share, beating the Zacks Consensus Estimate of $2.24 per share. This compares to earnings of $2.2 per share a year ago.
Read full article
Seed 1H results reflect continued value capture on latest in-demand germplasm and trait technologies, including licensing growth Crop Protection 1H demand for new products and focus on operational excellence helped offset competitive pricing dynamics Full-year 2026 guidance3 increased to reflect strong first half performance, incremental benefits on controllable levers, and growth platforms Corteva remains on-track to complete the planned separation, targeting October 1 Vylor spin-off date INDIANAPOLIS, Ind., July 30, 2026 /PRNewswire/ -- Corteva, Inc. (NYSE: CTVA) ("Corteva" or the "Company") today reported financial results for the second quarter and six months ended June 30, 2026.
Read full article
Corteva's earnings beat, rising estimates and innovation pipeline support momentum, but premium valuation and separation costs raise execution risk.
Read full article
CTVA's Seed pricing, Crop Protection volumes and cost savings support growth ahead of its planned fourth-quarter 2026 separation.
Read full article